Sleep Optimization for Prediabetes: How Better Sleep Can Lower Your Blood Sugar
Evidence-based strategies for improving sleep to manage prediabetes. Learn how sleep duration, quality, and timing affect glucose metabolism and insulin sensitivity.
Evidence-based strategies for improving sleep to manage prediabetes. Learn how sleep duration, quality, and timing affect glucose metabolism and insulin sensitivity.
How alcohol, cannabis, caffeine and opioids fit into a low-testosterone evaluation, with study findings, hormone testing and fertility considerations.
A clinical review of supplements and lifestyle interventions for secondary hypogonadism, including vitamin D, zinc, ashwagandha, fenugreek, and weight loss, grounded in RCT and meta-analysis data.
Evidence-based guide to workplace accommodations for secondary hypogonadism, including schedule flexibility, fatigue management, and legal protections under the ADA.
Evidence-based guide to how relationships, social support, workplace dynamics, and psychosocial factors influence tendinopathy outcomes, rehabilitation adherence, and pain perception.
Evidence-based guide to supplements for tendinopathy, covering collagen peptides, vitamin C, omega-3s, curcumin, glyceryl trinitrate, and more. Includes RCT data, doses, and clinical guidelines.
A clinical guide to managing the costs of Type 2 diabetes, from insulin price caps and GLP-1 coverage to HSA strategies, prior authorization, and the economic case for lifestyle intervention.
Evidence-based monitoring schedule for liothyronine (Cytomel) therapy including lab panels, exam intervals, dose-adjustment timelines, and safety checkpoints cited from ATA, ETA, and primary literature.
A clinician-level review of liothyronine T3 approval status, prescribing frameworks, and formulation availability across the United States, European Union, Canada, and United Kingdom.
Evidence-based guide to storing liothyronine T3 tablets correctly, understanding shelf life, and recognizing degradation. Includes FDA labeling data, USP stability standards, and clinical guidance.
Complete guide to Aetna (CVS Health) coverage of liraglutide for weight loss and type 2 diabetes, including prior authorization criteria, step therapy requirements, formulary placement, and how to appeal a denial.
A clinical deep-dive into how liraglutide was developed, its mechanism of action, key trials like SCALE and LEADER, FDA approvals, and what the arrival of generic versions means for patients.
A clinical deep-dive into liraglutide's manufacturing process, supply chain history, FDA shortage events, and what prescribers and patients should know about current availability.
A physician-level breakdown of how liraglutide works, from GLP-1 receptor binding and cAMP signaling to appetite suppression, gastric slowing, and beta-cell preservation.
Evidence-based liraglutide monitoring schedule covering baseline labs, ongoing bloodwork, renal panels, thyroid surveillance, and clinical exams required during GLP-1 therapy.
Evidence-based monitoring guide for adults aged 50-64 taking liraglutide. Covers baseline labs, renal function tracking, cardiovascular risk panels, GI safety, and dose-titration checkpoints.
A guide to liraglutide self-injection technique, including site selection, dose titration, needle handling, and troubleshooting common errors.
Evidence-based guide to liraglutide use in transplant recipients, people living with HIV, and other special populations. Covers dosing, safety signals, drug interactions, and clinical trial data.
Learn which foods, supplements and painkillers need review with lisinopril, how to read potassium labels, and when lab checks matter.
Evidence-based guide to lisinopril safety in geriatric patients (65+), covering renal risks, hypotension, falls, drug interactions, and deprescribing strategies.
Lisinopril requires no dose adjustment in liver disease. Learn why its unique pharmacokinetics make it one of the safest ACE inhibitors for patients with hepatic impairment.
Evidence-based guidance on what to do when you miss a dose of lisinopril, including timing rules, blood pressure rebound risks, and clinician-recommended strategies to maintain ACE inhibitor adherence.
What to do after taking too much lisinopril, why 80 mg is not a poisoning threshold, and how symptoms, kidney function, and timing guide assessment.
Lisinopril is not a controlled substance; it's a prescription-only ACE inhibitor. See how US, EU, UK, and Canada labels differ on dosing and warnings.
How to store lisinopril correctly, what affects its chemical stability, and when to replace expired tablets. FDA data, USP standards, and real-world degradation studies reviewed.
A guide to lisinopril safety for adults aged 18 to 29, covering side effects, pregnancy risks, fertility, monitoring, and lifestyle considerations.
A clinical review of hypoallergenic claims for Smashbox Photo Finish primer, common allergenic ingredients in cosmetic primers, contact dermatitis symptoms, and evidence-based patch testing guidance.
Evidence-based resmetirom (Rezdiffra) dosing protocol for metabolic dysfunction-associated steatohepatitis (MASH), including weight-based dosing, titration, monitoring, and comparison with vitamin E therapy.
Evidence-based guide to vitamins and supplements that may reduce crested wheatgrass allergy symptoms, including quercetin, butterbur, vitamin D, vitamin C, and probiotics.
Evidence-based guide on how dietary changes may reduce Blue Lyme Grass (Leymus arenarius) pollen allergy symptoms, including anti-inflammatory foods, oral allergy syndrome triggers, and gut-microbiome strategies.
Evidence-based review of natural and integrative strategies for crested wheatgrass pollen allergies, including sublingual immunotherapy, quercetin, nasal saline irrigation, butterbur, and lifestyle modifications.
Metformin commonly causes gastrointestinal side effects including nausea, diarrhea, bloating, and abdominal pain. Learn why these occur, how often, and evidence-based strategies to reduce them.
BCBSIL covers metformin on most plans at Tier 1 generic pricing. Learn copay ranges, formulary tiers, prior authorization rules, and how off-label longevity prescriptions affect coverage.
Find out whether Christiana Care Health System covers metformin, including formulary tiers, copay estimates, extended-release vs. immediate-release coverage, and how to verify your specific plan benefits.
Fallon Community Health Plan covers metformin on its lowest formulary tier. Learn about FCHP copays, prior authorization rules, extended-release options, and how to confirm your specific plan benefits.
Florida Blue covers metformin on most formulary tiers. Learn copay ranges, prior authorization requirements, preferred forms, and how to confirm your specific plan benefits.
Gateway Health Plan covers metformin on its formulary as a preferred generic. Learn about copay tiers, extended-release coverage, prior authorization rules, and how to confirm your specific benefits.
Health Net typically covers metformin as a preferred generic on its formulary. Learn about tier placement, prior authorization requirements, copay ranges, and how to confirm your specific plan's coverage.
Find out whether Horizon BCBS of New Jersey covers metformin for diabetes and off-label longevity use, including formulary tiers, copay estimates, prior authorization rules, and how to appeal a denial.
Independence Blue Cross covers metformin on its lowest formulary tier. Learn about copay costs, prior authorization rules, extended-release options, and off-label longevity use under IBX plans.
Sharp Health Plan typically covers metformin as a preferred generic drug. Learn about formulary tiers, prior authorization requirements, costs, and how to confirm your specific coverage.
UPMC Health Plan covers metformin on its preferred drug formulary. Learn about copay tiers, prior authorization requirements, and how to get metformin covered under your UPMC plan.
A clinical review of metformin's long-term safety profile covering cardiovascular outcomes, cancer risk, lactic acidosis, vitamin B12 depletion, and emerging longevity data from UKPDS, DPP, and TAME.
Standard losartan starting dose for adults is 50 mg once daily, titrated up to 100 mg if blood pressure stays above goal after several weeks.
Losartan dosing after age 65: when 25 or 50 mg is used, kidney and potassium monitoring, trial results, dose timing and supervised medication reduction.
Evidence-based monitoring guide for losartan in adults 65 and older, covering renal function, potassium, blood pressure targets, fall risk, and drug interactions.
How liver disease affects losartan metabolism, why dose reduction matters, and what clinicians should know about prescribing losartan in patients with hepatic impairment.
Evidence-based monitoring guide for adults aged 50-64 taking losartan, covering kidney function, potassium, blood pressure targets, polypharmacy, and follow-up lab schedules.
Losartan extra-dose and overdose evidence: symptoms, actual poison-center findings, charcoal and dialysis limits, and exposure-specific assessment.
Before switching losartan, check whether it treats blood pressure, diabetic kidney disease, or another condition, and what the replacement needs to do.
A clinical guide to monitoring losartan in young adults aged 18 to 29, covering baseline labs, potassium and kidney function checks, blood pressure targets, fertility considerations, and long-term follow-up schedules.
A step-by-step guide to obtaining a low-dose naltrexone (LDN) prescription in Nebraska, including telehealth options, compounding pharmacies, costs, and what labs your provider may order first.
Evidence-based guide to low-dose naltrexone dosing in adults aged 30, 49, covering initiation, titration, timing, and clinical considerations for off-label use in fibromyalgia, autoimmune conditions, and chronic inflammation.
Anthem (Elevance Health) coverage policy for low-dose naltrexone (LDN): prior authorization criteria, formulary tier, step therapy requirements, appeal process, and cost-saving alternatives.
A clinical guide to food and supplement interactions with low-dose naltrexone (LDN), including timing, absorption effects, and what to avoid for optimal efficacy.
How low-dose naltrexone (LDN) works at the molecular level. Opioid receptor blockade, glial modulation, endorphin rebound, and immune regulation explained with PubMed-cited evidence.
A complete monitoring schedule for low-dose naltrexone (LDN), including baseline labs, liver function tests, inflammatory markers, thyroid panels, and follow-up exam timing backed by clinical evidence.
Clinical guide to managing low-dose naltrexone (LDN) overdose and accidental excess doses, including symptoms, timelines, opioid receptor blockade duration, and when to seek emergency care.
A clinical review of naltrexone's patent history, current compounding status, FDA-approved formulations, and the regulatory path for a dedicated low-dose naltrexone product.
A clinician-grade review of low-dose naltrexone (LDN) safety signals, FDA regulatory actions, compounding pharmacy oversight, and adverse-event data from published trials and FAERS reports.